Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
Yun Zhao,
No information about this author
Ying Tang,
No information about this author
Qi Wang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 4, 2025
With
the
consistent
occurrence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
prevalence
various
ocular
complications
has
increased
over
time.
SARS-CoV-2
infection
been
shown
to
have
neurotropism
and
therefore
lead
not
only
peripheral
inflammatory
responses
but
also
neuroinflammation.
Because
receptor
for
SARS-CoV-2,
angiotensin-converting
enzyme
(ACE2),
can
be
found
in
many
intraocular
tissues,
disease
2019
(COVID-19)
may
contribute
persistent
neuroinflammation,
microcirculation
dysfunction
symptoms.
Increased
awareness
neuroinflammation
future
research
on
interventional
strategies
are
important
improving
long-term
outcomes,
reducing
burden,
quality
life.
Therefore,
aim
this
review
is
focus
discuss
current
evidence
perspectives,
especially
possible
connections
between
conditions
potential
treatment
strategies.
Language: Английский
Delayed acute retinal necrosis complicated by central retinal artery occlusion post-SARS-CoV-2 recovery: clinical practice and review
Rui Jiang,
No information about this author
Dan Lin,
No information about this author
Feng Han
No information about this author
et al.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
2(1)
Published: Feb. 14, 2025
Language: Английский
A Case of Uveitis after Viral Infection
相宏 万
No information about this author
Asian Case Reports in Emergency Medicine,
Journal Year:
2025,
Volume and Issue:
13(02), P. 140 - 145
Published: Jan. 1, 2025
Language: Английский
Brief research report: Transcriptional blockade of angiotensin converting enzyme 2 modelled in human retinal pigment epithelial cells
Frontiers in Drug Discovery,
Journal Year:
2024,
Volume and Issue:
4
Published: Oct. 7, 2024
As
a
key
host
protein
involved
in
cellular
infection
by
the
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV-2),
angiotensin
converting
enzyme
(ACE)2
is
an
ideal
target
for
antiviral
drugs.
Manipulation
of
transcription
provides
opportunity
graduated
blockade
that
preserves
physiological
functions.
We
sought
to
develop
model
system
evaluating
manipulation
ACE2
gene
using
human
retinal
pigment
epithelium.
Retinal
epithelial
cell
isolates
were
prepared
from
posterior
eyecups
(n
=
11
individual
isolates).
The
cells
expressed
transcript
and
protein,
expression
was
not
induced
hypoxia
mimetic
dimethyloxaloylglycine,
or
inflammatory
cytokine
IL-1β.
factors
predicted
silico
cross-referenced
with
transcriptome,
five
candidate
identified:
ETS
proto-oncogene
1
factor
(ETS1),
nuclear
I
C
(NFIC),
receptor
subfamily
2
group
member
(NR2C1),
TEA
domain
(TEAD1),
zinc
finger
384
(ZNF384).
candidates
individually
targeted
transfection
small
interfering
(si)RNA.
Knockdowns
reduced
mean
all
comparison
transfected
control
non-targeted
siRNA.
Mean
under
condition
NR2C1
knockdown,
but
ETS1,
NFIC,
TEAD1,
ZNF384
knockdowns.
Our
findings
build
on
previous
work
demonstrating
potential
drugging
transcription.
Importantly,
we
show
value
epithelium
as
transcriptional
blockade,
possible
approach
treating
SARS-CoV-2
infection.
Brief
Research
Report.
Language: Английский